Adult Brtl/+ mouse model of osteogenesis imperfecta demonstrates anabolic response to sclerostin antibody treatment with increased bone mass and strength

被引:0
|
作者
B. P. Sinder
L. E. White
J. D. Salemi
M. S. Ominsky
M. S. Caird
J. C. Marini
K. M. Kozloff
机构
[1] University of Michigan,Orthopaedic Research Laboratories, Department of Orthopaedic Surgery
[2] University of Michigan,Department of Biomedical Engineering
[3] Amgen,Department of Metabolic Disorders
[4] Inc.,Bone and Extracellular Matrix Branch
[5] National Institute of Child Health and Human Development,undefined
[6] NIH,undefined
来源
关键词
Mouse model; Osteogenesis imperfecta; Osteoporosis; Sclerostin antibody;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2097 / 2107
页数:10
相关论文
共 50 条
  • [1] Adult Brtl/+ mouse model of osteogenesis imperfecta demonstrates anabolic response to sclerostin antibody treatment with increased bone mass and strength
    Sinder, B. P.
    White, L. E.
    Salemi, J. D.
    Ominsky, M. S.
    Caird, M. S.
    Marini, J. C.
    Kozloff, K. M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2014, 25 (08) : 2097 - 2107
  • [2] Rapidly growing Brtl/ plus mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatment
    Sinder, Benjamin P.
    Salemi, Joseph D.
    Ominsky, Michael S.
    Caird, Michelle S.
    Marini, Joan C.
    Kozloff, Kenneth M.
    [J]. BONE, 2015, 71 : 115 - 123
  • [3] Sclerostin Antibody Improves Skeletal Parameters in a Brtl/+ Mouse Model of Osteogenesis Imperfecta
    Sinder, Benjamin P.
    Eddy, Mary M.
    Ominsky, Michael S.
    Caird, Michelle S.
    Marini, Joan C.
    Kozloff, Kenneth M.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (01) : 73 - 80
  • [4] Low Dose of Bisphosphonate Enhances Sclerostin Antibody-Induced Trabecular Bone Mass Gains in Brtl/ plus Osteogenesis Imperfecta Mouse Model
    Olvera, Diana
    Stolzenfeld, Rachel
    Marini, Joan C.
    Caird, Michelle S.
    Kozloff, Kenneth M.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 (07) : 1272 - 1282
  • [5] Increased susceptibility to microdamage in Brtl/+ mouse model for osteogenesis imperfecta
    Davis, Mathieu S.
    Kovacic, Bethany L.
    Marini, Joan C.
    Shih, Albert J.
    Kozloff, Kenneth M.
    [J]. BONE, 2012, 50 (03) : 784 - 791
  • [6] SCLEROSTIN ANTIBODY INCREASED BONE MASS AND REDUCED FRACTURES IN OSTEOGENESIS IMPERFECTA MICE
    Devogelaer, Jean-Pierre
    Behets, Catherine
    Ammann, Patrick
    Ominsky, Mike S.
    Chappard, Daniel
    Manicourt, Daniel H.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S74 - S74
  • [7] Single dose of bisphosphonate preserves gains in bone mass following cessation of sclerostin antibody in Brtl/ plus osteogenesis imperfecta model
    Perosky, Joseph E.
    Khoury, Basma M.
    Jenks, Terese N.
    Ward, Ferrous S.
    Cortright, Kai
    Meyer, Bethany
    Barton, David K.
    Sinder, Benjamin P.
    Marini, Joan C.
    Caird, Michelle S.
    Kozloff, Kenneth M.
    [J]. BONE, 2016, 93 : 79 - 85
  • [8] Gene expression profiling of sclerostin antibody-induced therapeutic response in growing Brtl/ plus mouse model of osteogenesis imperfecta
    Sung, Hsiao Hsin
    Surowiec, Rachel
    Falzon, Rebecca
    Battle, Lauren
    Stephan, Chris
    Caird, Michelle S.
    Kozloff, Kenneth M.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 124 - 124
  • [9] Tissue level material composition and mechanical properties in Brtl/plus mouse model of Osteogenesis Imperfecta after sclerostin antibody treatment
    Lloyd, William R.
    Sinder, Benjamin P.
    Salemi, Joseph
    Ominsky, Michael S.
    Marini, Joan C.
    Caird, Michelle S.
    Morris, Michael D.
    Kozloff, Kenneth M.
    [J]. PHOTONIC THERAPEUTICS AND DIAGNOSTICS XI, 2015, 9303
  • [10] Effect of sclerostin antibody treatment in a mouse model of severe osteogenesis imperfecta
    Roschger, Andreas
    Roschger, Paul
    Keplingter, Petra
    Klaushofer, Klaus
    Abdullah, Sami
    Kneissel, Michaela
    Rauch, Frank
    [J]. BONE, 2014, 66 : 182 - 188